S&P Raises 2001 EPS Estimates for Biovail Corp.

Acquisition expected to contribute to bottom line

Company: Biovail Corp (BVF )

Fiscal year ending: Dec-01

Prior 1.02

New: 1.25

Rationale: Reflects purchase of Cardizem line

Before it's here, it's on the Bloomberg Terminal. LEARN MORE